• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

二级和三级神经胶质瘤中的突变特征和克隆结构。

Mutational landscape and clonal architecture in grade II and III gliomas.

机构信息

1] Department of Neurosurgery, Nagoya University School of Medicine, Nagoya, Japan. [2] Department of Pathology and Tumor Biology, Kyoto University, Kyoto, Japan.

Human Genome Center, Institute of Medical Science, The University of Tokyo, Tokyo, Japan.

出版信息

Nat Genet. 2015 May;47(5):458-68. doi: 10.1038/ng.3273. Epub 2015 Apr 13.

DOI:10.1038/ng.3273
PMID:25848751
Abstract

Grade II and III gliomas are generally slowly progressing brain cancers, many of which eventually transform into more aggressive tumors. Despite recent findings of frequent mutations in IDH1 and other genes, knowledge about their pathogenesis is still incomplete. Here, combining two large sets of high-throughput sequencing data, we delineate the entire picture of genetic alterations and affected pathways in these glioma types, with sensitive detection of driver genes. Grade II and III gliomas comprise three distinct subtypes characterized by discrete sets of mutations and distinct clinical behaviors. Mutations showed significant positive and negative correlations and a chronological hierarchy, as inferred from different allelic burdens among coexisting mutations, suggesting that there is functional interplay between the mutations that drive clonal selection. Extensive serial and multi-regional sampling analyses further supported this finding and also identified a high degree of temporal and spatial heterogeneity generated during tumor expansion and relapse, which is likely shaped by the complex but ordered processes of multiple clonal selection and evolutionary events.

摘要

二级和三级胶质瘤通常是进展缓慢的脑癌,其中许多最终会转化为更具侵袭性的肿瘤。尽管最近发现 IDH1 和其他基因经常发生突变,但对其发病机制的了解仍不完整。在这里,我们结合了两组高通量测序数据,描绘了这些胶质瘤类型中遗传改变和受影响途径的全貌,敏感地检测到了驱动基因。二级和三级胶质瘤包括三个不同的亚型,其特征是存在离散的突变集和不同的临床行为。突变显示出显著的正相关和负相关以及时间层次结构,这是从共存突变中不同等位基因负担推断出来的,表明驱动克隆选择的突变之间存在功能相互作用。广泛的连续和多区域采样分析进一步支持了这一发现,并确定了在肿瘤扩张和复发过程中产生的高度时空异质性,这可能是由多个克隆选择和进化事件的复杂但有序过程塑造的。

相似文献

1
Mutational landscape and clonal architecture in grade II and III gliomas.二级和三级神经胶质瘤中的突变特征和克隆结构。
Nat Genet. 2015 May;47(5):458-68. doi: 10.1038/ng.3273. Epub 2015 Apr 13.
2
PI3 kinase mutations and mutational load as poor prognostic markers in diffuse glioma patients.PI3 激酶突变和突变负荷作为弥漫性神经胶质瘤患者的不良预后标志物。
Acta Neuropathol Commun. 2015 Dec 23;3:88. doi: 10.1186/s40478-015-0265-4.
3
Characterizing temporal genomic heterogeneity in pediatric high-grade gliomas.描述儿科高级别胶质瘤的时间基因组异质性。
Acta Neuropathol Commun. 2017 Oct 30;5(1):78. doi: 10.1186/s40478-017-0479-8.
4
DNA methylation, transcriptome and genetic copy number signatures of diffuse cerebral WHO grade II/III gliomas resolve cancer heterogeneity and development.弥漫性脑世界卫生组织分级 II/III 级神经胶质瘤的 DNA 甲基化、转录组和遗传拷贝数特征解析肿瘤异质性和发生。
Acta Neuropathol Commun. 2019 Apr 25;7(1):59. doi: 10.1186/s40478-019-0704-8.
5
IDH1 status is significantly different between high-grade thalamic and superficial gliomas.异柠檬酸脱氢酶1(IDH1)状态在高级别丘脑胶质瘤和浅表性胶质瘤之间存在显著差异。
Cancer Biomark. 2017 Aug 23;20(2):183-189. doi: 10.3233/CBM-170175.
6
Clinicopathologic implications of NF1 gene alterations in diffuse gliomas.弥漫性胶质瘤中NF1基因改变的临床病理意义
Hum Pathol. 2015 Sep;46(9):1323-30. doi: 10.1016/j.humpath.2015.05.014. Epub 2015 May 30.
7
Epigenetic silencing of XAF1 in high-grade gliomas is associated with IDH1 status and improved clinical outcome.XAF1在高级别胶质瘤中的表观遗传沉默与异柠檬酸脱氢酶1(IDH1)状态及改善的临床预后相关。
Oncotarget. 2017 Feb 28;8(9):15071-15084. doi: 10.18632/oncotarget.14748.
8
ZEB1 expression is increased in IDH1-mutant lower-grade gliomas.在异柠檬酸脱氢酶1(IDH1)突变的低级别胶质瘤中,锌指E盒结合蛋白1(ZEB1)的表达增加。
J Neurooncol. 2016 Oct;130(1):111-122. doi: 10.1007/s11060-016-2240-8. Epub 2016 Aug 27.
9
Molecular genetic profiling reveals novel association between FLT3 mutation and survival in glioma.分子遗传学分析揭示了 FLT3 突变与胶质瘤患者生存的新关联。
J Neurooncol. 2020 Jul;148(3):473-480. doi: 10.1007/s11060-020-03567-9. Epub 2020 Jun 24.
10
Use of telomerase promoter mutations to mark specific molecular subsets with reciprocal clinical behavior in IDH mutant and IDH wild-type diffuse gliomas.在 IDH 突变型和 IDH 野生型弥漫性胶质瘤中,使用端粒酶启动子突变来标记具有相互临床行为的特定分子亚群。
J Neurosurg. 2018 Apr;128(4):1102-1114. doi: 10.3171/2016.11.JNS16973. Epub 2017 Jun 16.

引用本文的文献

1
Polyphenol-Based Nutritional Strategies Combined With Exercise for Brain Function and Glioma Control: Focus on Epigenetic Modifications, Cognitive Function, Learning and Memory Processes.基于多酚的营养策略联合运动对脑功能和胶质瘤控制的影响:聚焦于表观遗传修饰、认知功能、学习和记忆过程
Food Sci Nutr. 2025 Aug 10;13(8):e70758. doi: 10.1002/fsn3.70758. eCollection 2025 Aug.
2
Prediction of 1p/19q state in glioma by integrated deep learning method based on MRI radiomics.基于MRI影像组学的集成深度学习方法预测胶质瘤中的1p/19q状态
BMC Cancer. 2025 Jul 28;25(1):1228. doi: 10.1186/s12885-025-14454-9.
3
Revisiting prognosis of oligodendroglioma patients in the 2021 WHO classification: incremental value of imaging features.
重新审视2021年世界卫生组织分类中少突胶质细胞瘤患者的预后:影像特征的增量价值。
Eur Radiol. 2025 Jul 9. doi: 10.1007/s00330-025-11768-x.
4
Assessment of CDKN2A homozygous and heterozygous deletions in gliomas across multiple detection platforms.在多个检测平台上评估胶质瘤中CDKN2A基因的纯合和杂合缺失。
BMC Cancer. 2025 Jun 5;25(1):1007. doi: 10.1186/s12885-025-14266-x.
5
Rapid diagnosis of adult-type diffuse glioma using a layered scheme.使用分层方案对成人型弥漫性胶质瘤进行快速诊断。
BMC Med. 2025 Jun 2;23(1):325. doi: 10.1186/s12916-025-04124-9.
6
Unlocking new horizons: advances in treating IDH-mutant, 1p/19q-codeleted oligodendrogliomas.开启新视野:IDH 突变型、1p/19q 共缺失少突胶质细胞瘤的治疗进展
Discov Oncol. 2025 May 31;16(1):971. doi: 10.1007/s12672-025-02815-6.
7
Genomic landscape of diffuse glioma revealed by whole genome sequencing.全基因组测序揭示的弥漫性胶质瘤的基因组图谱
Nat Commun. 2025 May 7;16(1):4233. doi: 10.1038/s41467-025-59156-9.
8
Establishment and validation of a nomogram for predicting IDH-wildtype glioblastomas in nonenhancing adult-type diffuse gliomas.预测非强化型成人型弥漫性胶质瘤中异柠檬酸脱氢酶野生型胶质母细胞瘤的列线图的建立与验证
Neurooncol Adv. 2025 Feb 8;7(1):vdaf035. doi: 10.1093/noajnl/vdaf035. eCollection 2025 Jan-Dec.
9
1p and/or 19q polysomy is an adverse prognostic factor in oligodendrogliomas, and easy to detect by automated FISH.1p和/或19q多体性是少突胶质细胞瘤的不良预后因素,且易于通过自动化荧光原位杂交(FISH)检测到。
PLoS One. 2025 May 2;20(5):e0322809. doi: 10.1371/journal.pone.0322809. eCollection 2025.
10
Targeting IDH1 mutation-driven Nrf2 signaling to suppress malignant behavior in fibrosarcoma cells.靶向异柠檬酸脱氢酶1(IDH1)突变驱动的核因子E2相关因子2(Nrf2)信号传导以抑制纤维肉瘤细胞的恶性行为
Toxicol Res. 2025 Feb 20;41(3):267-278. doi: 10.1007/s43188-025-00284-1. eCollection 2025 May.